139 related articles for article (PubMed ID: 36863505)
1. A computational study on the biotransformation of alkenylbenzenes by a selection of CYPs: Reflections on their possible bioactivation.
Pedroni L; Louisse J; Dorne JCM; Dall'Asta C; Dellafiora L
Toxicology; 2023 Apr; 488():153471. PubMed ID: 36863505
[TBL] [Abstract][Full Text] [Related]
2. A Computational Inter-Species Study on Safrole Phase I Metabolism-Dependent Bioactivation: A Mechanistic Insight into the Study of Possible Differences among Species.
Pedroni L; Louisse J; Punt A; Dorne JLCM; Dall'Asta C; Dellafiora L
Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828409
[TBL] [Abstract][Full Text] [Related]
3. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.
Rietjens IM; Boersma MG; van der Woude H; Jeurissen SM; Schutte ME; Alink GM
Mutat Res; 2005 Jul; 574(1-2):124-38. PubMed ID: 15914212
[TBL] [Abstract][Full Text] [Related]
4. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
Martati E; Boersma MG; Spenkelink A; Khadka DB; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2011 Jun; 24(6):818-34. PubMed ID: 21446753
[TBL] [Abstract][Full Text] [Related]
5. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.
Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329
[TBL] [Abstract][Full Text] [Related]
6. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
Randerath K; Haglund RE; Phillips DH; Reddy MV
Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
[TBL] [Abstract][Full Text] [Related]
7. Human cytochrome p450 enzyme specificity for bioactivation of safrole to the proximate carcinogen 1'-hydroxysafrole.
Jeurissen SM; Bogaards JJ; Awad HM; Boersma MG; Brand W; Fiamegos YC; van Beek TA; Alink GM; Sudhölter EJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2004 Sep; 17(9):1245-50. PubMed ID: 15377158
[TBL] [Abstract][Full Text] [Related]
8. Myristicin and Elemicin: Potentially Toxic Alkenylbenzenes in Food.
Götz ME; Sachse B; Schäfer B; Eisenreich A
Foods; 2022 Jul; 11(13):. PubMed ID: 35804802
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in silico study on consequences of combined exposure to the food-borne alkenylbenzenes estragole and safrole.
Yang S; Kawai T; Wesseling S; Rietjens IMCM
Toxicol In Vitro; 2022 Mar; 79():105290. PubMed ID: 34861381
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based kinetic modeling of the bioactivation of myristicin.
Al-Malahmeh AJ; Al-Ajlouni A; Wesseling S; Soffers AE; Al-Subeihi A; Kiwamoto R; Vervoort J; Rietjens IM
Arch Toxicol; 2017 Feb; 91(2):713-734. PubMed ID: 27334372
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of Alkenylbenzenes in Plants: Flavours and Possibly Toxic Plant Metabolites.
Götz ME; Eisenreich A; Frenzel J; Sachse B; Schäfer B
Plants (Basel); 2023 May; 12(11):. PubMed ID: 37299054
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach.
Castell JV; Donato MT; Gómez-Lechón MJ
Exp Toxicol Pathol; 2005 Jul; 57 Suppl 1():189-204. PubMed ID: 16092727
[TBL] [Abstract][Full Text] [Related]
13. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice.
Phillips DH; Reddy MV; Randerath K
Carcinogenesis; 1984 Dec; 5(12):1623-8. PubMed ID: 6499113
[TBL] [Abstract][Full Text] [Related]
14. Physiologically based biokinetic (PBBK) modeling of safrole bioactivation and detoxification in humans as compared with rats.
Martati E; Boersma MG; Spenkelink A; Khadka DB; van Bladeren PJ; Rietjens IM; Punt A
Toxicol Sci; 2012 Aug; 128(2):301-16. PubMed ID: 22588462
[TBL] [Abstract][Full Text] [Related]
15. AP-1 and SP1 trans-activate the expression of hepatic CYP1A1 and CYP2A6 in the bioactivation of AFB
Deng J; Yang JC; Feng Y; Xu ZJ; Kuča K; Liu M; Sun LH
Sci China Life Sci; 2024 Jul; 67(7):1468-1478. PubMed ID: 38703348
[TBL] [Abstract][Full Text] [Related]
16. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
17. Herbal bioactivation, molecular targets and the toxicity relevance.
Chen XW; Serag ES; Sneed KB; Zhou SF
Chem Biol Interact; 2011 Jul; 192(3):161-76. PubMed ID: 21459083
[TBL] [Abstract][Full Text] [Related]
18. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
[TBL] [Abstract][Full Text] [Related]
19. Effect of plant extracts on the genotoxicity of 1'-hydroxy alkenylbenzenes.
Marabini L; Galli CL; La Fauci P; Marinovich M
Regul Toxicol Pharmacol; 2019 Jul; 105():36-41. PubMed ID: 30935955
[TBL] [Abstract][Full Text] [Related]
20. Alkenylbenzenes in Foods: Aspects Impeding the Evaluation of Adverse Health Effects.
Eisenreich A; Götz ME; Sachse B; Monien BH; Herrmann K; Schäfer B
Foods; 2021 Sep; 10(9):. PubMed ID: 34574258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
